Atopic Dermatitis

Amy S. Paller, MD, of Northwestern University Feinberg School of Medicine, discussed recent developments in atopic dermatitis and what’s coming up in the pipeline.

In this video, Emma Guttman-Yassky, MD, PhD, Waldman Professor and System Chair in The Kimberly and Eric J. Waldman Department of Dermatology at the Icahn School of Medicine at Mount Sinai, discusses recent developments in the treatment of atopic dermatitis.

In this video, Emma Guttman-Yassky, MD, PhD, Waldman Professor and System Chair in The Kimberly and Eric J. Waldman Department of Dermatology at the Icahn School of Medicine at Mount Sinai, discusses what's in the pipeline for atopic dermatitis.

Daniel Gutierrez, MD, of NYU Grossman School of Medicine, discussed risk factors of atopic dermatitis.

In this video, Emma Guttman-Yassky, MD, PhD, Waldman Professor and System Chair in The Kimberly and Eric J. Waldman Department of Dermatology at the Icahn School of Medicine at Mount Sinai, discusses biologic treatments for atopic dermatitis, and how she positions them.

Amy S. Paller, MD, of Northwestern University Feinberg School of Medicine, discussed how to approach treatment of mild-to-moderate vs. moderate-to-severe atopic dermatitis.

In this video, Emma Guttman-Yassky, MD, PhD, Waldman Professor and System Chair in The Kimberly and Eric J. Waldman Department of Dermatology at the Icahn School of Medicine at Mount Sinai, discusses how dermatologists improve patient and caregiver education in atopic dermatitis care.

Amy S. Paller, MD, of Northwestern University Feinberg School of Medicine, discussed how patient age and treatment history can impact management of atopic dermatitis.

Daniel Gutierrez, MD, of NYU Grossman School of Medicine, discussed the development of JAK inhibitors for atopic dermatitis.

Daniel Gutierrez, MD, of NYU Grossman School of Medicine, discussed the atopic dermatitis treatment pipeline.